EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis

In this article, the 2009 European League Against Rheumatism (EULAR) recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have been updated. The 2009 recommendations were on the management of primary small and medium vessel vasculitis. The 2015...

Full description

Saved in:

Bibliographic Details
Published in:	Annals of the rheumatic diseases Vol. 75; no. 9; pp. 1583 - 1594
Main Authors:	Yates, M, Watts, R A, Bajema, I M, Cid, M C, Crestani, B, Hauser, T, Hellmich, B, Holle, J U, Laudien, M, Little, M A, Luqmani, R A, Mahr, A, Merkel, P A, Mills, J, Mooney, J, Segelmark, M, Tesar, V, Westman, K, Vaglio, A, Yalçındağ, N, Jayne, D R, Mukhtyar, C
Format:	Journal Article
Language:	English
Published:	England Elsevier Limited 01.09.2016 BMJ Publishing Group
Subjects:	Adeno-associated virus Adrenocortical hormones Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - pathology Antibodies Apheresis Biopsy - standards Blood vessels Clinical Medicine Corticosteroides Disease Management Humans Immunosuppressive Agents - therapeutic use Klinisk medicin Medical and Health Sciences Medical protocols Medicin och hälsovetenskap Plasma Exchange Protocols clínics Recurrence Remission (Medicine) Remission Induction - methods Retreatment - methods Vasculitis Vasos sanguinis Disease Activity Cyclophosphamide Corticosteroids Treatment Systemic vasculitis
ISSN:	0003-4967, 1468-2060, 1468-2060
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!